Evolving Therapeutic Strategies for the Classic Philadelphia-Negative Myeloproliferative Neoplasms

Evolving Therapeutic Strategies for the Classic Philadelphia-Negative Myeloproliferative Neoplasms

Despite the emergence of JAK inhibitors, there is a need for disease-modifying treatments for Philadelphia-negative myeloproliferative neoplasms (MPNs). JAK inhibitors ameliorate symptoms and address splenomegaly, but because of the heterogeneous contributors to the disease process, JAK inhibitor mo...

Full description

Bibliographic Details
Main Authors: Jason B. Kaplan, Brady L. Stein, Brandon McMahon, Francis J. Giles, Leonidas C. Platanias
Format: Article
Language:English
Published: Elsevier 2016-01-01
Series:EBioMedicine
Subjects:
Myeloproliferative neoplasm
Myelofibrosis
Therapy
Targeted
Novel
Combination
Online Access:http://www.sciencedirect.com/science/article/pii/S235239641630007X

Internet

http://www.sciencedirect.com/science/article/pii/S235239641630007X

Similar Items